老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

眾巢醫學

0.7029
-0.0187-2.59%
盤後：0.6740-0.0289-4.11%19:50 EDT
成交量：17.96萬
成交額：13.06萬
市值：1,775.10萬
市盈率：-6.86
高：0.7600
開：0.7100
低：0.6816
收：0.7216
52周最高：2.50
52周最低：0.6800
股本：2,525.39萬
流通股本：1,852.10萬
量比：0.06
換手率：0.97%
股息：- -
股息率：- -
每股收益(TTM):-0.1024
每股收益(LYR):-0.1236
淨資產收益率：-5.93%
總資產收益率：-2.90%
市淨率：0.88
市盈率(LYR):-5.69

資料載入中...

總覽公司新聞公告
2025/08/22

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/07/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/06/21

SEC問詢函

Form CORRESP - Correspondence
2025/06/07

SEC問詢函

Form CORRESP - Correspondence
2025/05/20

SEC問詢函

Form CORRESP - Correspondence
2025/05/07

SEC問詢函

Form CORRESP - Correspondence
2025/04/25

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/02/27

SEC問詢函

Form CORRESP - Correspondence
2024/04/30

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/05/12

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/05/09

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/05/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/05/08

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/01

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/23

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/02

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/26

超過5%披露

General statement of acquisition of beneficial ownership
2020/02/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/19

SEC問詢函

CORRESP [Cover] - Correspondence
更多